melatonin has been researched along with mdv 3100 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Chen, Z; Hou, Y; Hu, J; Liu, L; Sugimura, H; Tao, H; Wang, L; Yang, X; Zhang, C; Zhou, L | 1 |
1 other study(ies) available for melatonin and mdv 3100
Article | Year |
---|---|
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.
Topics: Acetylation; Androgen Antagonists; Animals; Antioxidants; Apoptosis; Benzamides; Biomarkers, Tumor; Carboxylic Ester Hydrolases; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lipids; Male; Melatonin; Mice; Mice, Inbred C57BL; Nitriles; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Sirtuin 1; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |